Product Information
PIPERACIL-TAZOBACT 3.375 GM VL is a generic product labeled by Sandoz Inc., priced at $3.4926 per EA under NDC 00781311395. Its NADAC has been published 102 times since Jul 17, 2024.
The High Outlier badge above means this manufacturer's average price in the Piperacillin and Tazobactam market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
3; .375 g/15mL; g/15mL
Manufacturer
Sandoz Inc.NDC
00781311395
Classification
Generic
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS; PARENTERAL
Last Updated
1/21/2026
Active Ingredients
PIPERACILLIN SODIUM; TAZOBACTAM SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA065362On Market Since
10/21/2010
Pharmacological Classes
Price Statistics
The NADAC for PIPERACIL-TAZOBACT 3.375 GM VL has been published 102 times since Jul 17, 2024, and over the history we have for it it has declined 23.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.4926 per EA |
|---|---|
| All-time high | $4.5612 (Oct 16, 2024) |
| All-time low | $2.8072 (May 21, 2025) |
| 52-week high | $3.6157 |
| 52-week low | $2.9972 |
| Median price | $3.4926 |
| Average price | $3.5325 |
| Largest weekly change | -17.8% (Oct 23, 2024) |
| Weeks tracked | 102 |
| Tracking since | Jul 17, 2024 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of PIPERACIL-TAZOBACT 3.375 GM VL?
The current National Average Drug Acquisition Cost (NADAC) for PIPERACIL-TAZOBACT 3.375 GM VL, manufactured by Sandoz Inc., is $3.4926 per EA (NDC 00781311395), effective Jun 24, 2026.
How has the price of PIPERACIL-TAZOBACT 3.375 GM VL changed over time?
Over the history we have for it, the NADAC for PIPERACIL-TAZOBACT 3.375 GM VL has declined 23.4%. It has been tracked across 102 weekly CMS publications since Jul 17, 2024.
What are the highest and lowest recorded NADAC prices for PIPERACIL-TAZOBACT 3.375 GM VL?
Since Jul 17, 2024, the NADAC for PIPERACIL-TAZOBACT 3.375 GM VL has ranged from a low of $2.8072 (May 21, 2025) to a high of $4.5612 (Oct 16, 2024), with a median of $3.4926 per EA.
Are there cheaper alternatives to PIPERACIL-TAZOBACT 3.375 GM VL?
2 NADAC-published products share the same active ingredient, strength, and dosage form as PIPERACIL-TAZOBACT 3.375 GM VL, but none are currently priced below it.
Who manufactures PIPERACIL-TAZOBACT 3.375 GM VL?
PIPERACIL-TAZOBACT 3.375 GM VL (NDC 00781311395) is labeled by Sandoz Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification